MAPK-mediated defense pathways against pore-forming toxins
MAPK-mediated defense pathways against pore-forming toxins
批准号:
8188216
负责人:
RAFFI V AROIAN
金额:
$30.08万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-01 至 2015-04-30
关键词:
AnimalsAntibioticsAutophagocytosisBackBacteriaBacterial InfectionsBacterial ToxinsBindingBiochemicalBiologicalBiological AssayCaenorhabditis elegansCell membraneCellsCellular Stress ResponseClostridiumCollaborationsComparative StudyCytolysisDataDefense MechanismsDevelopmentDiseaseElementsEndocytosisEnterococcus faecalisEventGenesGeneticGenetic ScreeningGenetic screening methodGenomicsGermanyGoalsHeadHeatingHeavy MetalsHomologous GeneHumanHypersensitivity skin testingHypoxia PathwayInfectionIntoxicationKnowledgeLaboratoriesLeadMAPK14 geneMammalian CellMammalsMediatingMediator of activation proteinMembraneMembrane Protein TrafficMetabolicMetabolismMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesModelingMolecularN-terminalNematodaOxidative StressPathogenesisPathway interactionsPharmaceutical PreparationsPhosphotransferasesProteinsRNA InterferenceRegulationResearchRoleSmall Interfering RNAStaphylococcus aureusStreptococcusSuggestionSystemTestingTherapeuticToxinUropathogenic E. coliVibrio choleraeVirulenceVirulence FactorsWorkdesignfightinggene discoveryhuman MAPK14 proteinin vivoinhibitor/antagonistjun Oncogenekeratinocytenovel therapeuticspathogenpathogenic bacteriapositional cloningrepairedresponseskillsstress-activated protein kinase 1
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The broad objective of this application is to understand how host cells defend themselves against pore-forming toxins made by pathogenic bacteria. The long term objective is to use this information for development of novel therapeutics that protects humans against bacterial infection by boosting cellular defenses against pore-forming toxins. Pore-forming toxins are the largest single group of bacterial virulence factors, comprising >25% of all protein toxins made by bacteria. They are important for the in vivo virulence of many major bacterial pathogens of humans, including Staphylococcus aureus and Streptococci. Caenorhabditis elegans has emerged as an important genetically-tractable in vivo system for studying how animal cells defend against pore-forming toxins in a manner relevant to mammals. c-JUN N-terminal Kinase (JNK) mitogen-activated protein kinase (MAPK) is a central regulator of induced cellular defenses to pore-forming toxins in C. elegans, regulating half of all PFT-induced defenses. Specific Aim I will use forward and reverse genetics, genetic and biochemical tests, quantitative intoxication assays, and expression analyses to assemble as completely as possible the C. elegans JNK PFT-induced defense pathway, heading both upstream of JNK towards initial pore-formation and downstream of JNK into regulated defense subpathways. Specific Aim II involves the use of mammalian cells treated with a medically relevant pore-forming toxin to ascertain how well C. elegans defenses are conserved in mammalian cells. Specific Aim III uses a unique and powerful set of assays developed in C. elegans to study the actual mechanisms by which the JNK PFT-induced defense pathway protects cells against PFT attack. An additional goal of Specific Aim III is to uncover new cellular mechanisms for PFT defenses.
PUBLIC HEALTH RELEVANCE: During infection, many disease-causing bacteria secrete pore-forming toxins that punch holes in cell membranes as a means towards damaging and disabling our cells. In this application, we will study how our cells fight back and protect themselves against these toxins. Our goal is to use this information to design new drugs that boost our own defenses against bacterial toxins and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Automated high throughput compound screening for broadly active anti-parasitic nematode drugs
-
批准号:10089408
-
项目类别:
-
资助金额:$65.84万
-
财政年份:2020
-
负责人:RAFFI V AROIAN
-
依托单位:
Tapping into an anthelmintic Bacillus thuringiensis crystal protein arsenal for human strongyloidiasis
-
批准号:10088404
-
项目类别:
-
资助金额:$20.64万
-
财政年份:2020
-
负责人:RAFFI V AROIAN
-
依托单位:
Automated high throughput compound screening for broadly active anti-parasitic nematode drugs
-
批准号:10590600
-
项目类别:
-
资助金额:$63.61万
-
财政年份:2020
-
负责人:RAFFI V AROIAN
-
依托单位:
Automated high throughput compound screening for broadly active anti-parasitic nematode drugs
-
批准号:10328540
-
项目类别:
-
资助金额:$37.44万
-
财政年份:2020
-
负责人:RAFFI V AROIAN
-
依托单位:
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans
-
批准号:10434691
-
项目类别:
-
资助金额:$45.07万
-
财政年份:2019
-
负责人:RAFFI V AROIAN
-
依托单位:
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans
-
批准号:9795199
-
项目类别:
-
资助金额:$52.7万
-
财政年份:2019
-
负责人:RAFFI V AROIAN
-
依托单位:
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans
-
批准号:10006858
-
项目类别:
-
资助金额:$50.97万
-
财政年份:2019
-
负责人:RAFFI V AROIAN
-
依托单位:
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans
-
批准号:10651707
-
项目类别:
-
资助金额:$45.07万
-
财政年份:2019
-
负责人:RAFFI V AROIAN
-
依托单位:
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humans
-
批准号:10192776
-
项目类别:
-
资助金额:$45.07万
-
财政年份:2019
-
负责人:RAFFI V AROIAN
-
依托单位:
Harnessing Transcriptomics to Identify and Test Novel Hookworm Vaccine Targets
-
批准号:9063524
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2015
-
负责人:RAFFI V AROIAN
-
依托单位:
Mining marine microbial natural products for anthelmintics leads
-
批准号:8701856
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2014
-
负责人:RAFFI V AROIAN
-
依托单位:
Mining marine microbial natural products for anthelmintics leads
-
批准号:8791868
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2014
-
负责人:RAFFI V AROIAN
-
依托单位:
p38-mediated defense pathway against pore-forming toxins
-
批准号:7856538
-
项目类别:
-
资助金额:$9.36万
-
财政年份:2009
-
负责人:RAFFI V AROIAN
-
依托单位:
p38-mediated defense pathway against pore-forming toxins
-
批准号:8048335
-
项目类别:
-
资助金额:$9.85万
-
财政年份:2006
-
负责人:RAFFI V AROIAN
-
依托单位:
C. elegans model of B. anthracis immunity & pathogenesis
-
批准号:7091844
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2006
-
负责人:RAFFI V AROIAN
-
依托单位:
p38-mediated defense pathway against pore-forming toxins
-
批准号:7676262
-
项目类别:
-
资助金额:$1.73万
-
财政年份:2006
-
负责人:RAFFI V AROIAN
-
依托单位:
p38-mediated defense pathway against pore-forming toxins
-
批准号:7225496
-
项目类别:
-
资助金额:$26.46万
-
财政年份:2006
-
负责人:RAFFI V AROIAN
-
依托单位:
p38-mediated defense pathway against pore-forming toxins
-
批准号:7615083
-
项目类别:
-
资助金额:$26.46万
-
财政年份:2006
-
负责人:RAFFI V AROIAN
-
依托单位:
C. elegans model of B. anthracis immunity & pathogenesis
-
批准号:7230177
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2006
-
负责人:RAFFI V AROIAN
-
依托单位:
p38-mediated defense pathway against pore-forming toxins
-
批准号:7049641
-
项目类别:
-
资助金额:$28.29万
-
财政年份:2006
-
负责人:RAFFI V AROIAN
-
依托单位:
海外基金